Unidade de Investigación en Cardioloxía Celular e Molecular
C.C.M.
Hospital Universitario La Paz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario La Paz (44)
2025
2024
-
Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial
The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 10, pp. 725-734
-
The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease
European Heart Journal Open, Vol. 4, Núm. 2
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial
International Journal of Cardiology, Vol. 391
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
-
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
European Journal of Heart Failure, Vol. 25, Núm. 7, pp. 936-955
2022
-
Clinical and therapeutic characterization of the ischemic cardiopathy in Spain. Importance of cardiac rehabilitation programs
Medicina Clinica Practica, Vol. 5, Núm. 3
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
-
The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study
International Journal of Cardiology, Vol. 361, pp. 116-123
2021
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48
2020
-
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry
European heart journal, Vol. 41, Núm. 18, pp. 1720-1729
2019
-
Role of age and comorbidities in mortality of patients with infective endocarditis
European Journal of Internal Medicine, Vol. 64, pp. 63-71
2018
-
Exercise-related severe cardiac events
Scandinavian Journal of Medicine and Science in Sports, Vol. 28, Núm. 4, pp. 1404-1411
-
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis
Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562
-
Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm
Europace, Vol. 20, Núm. 5, pp. 851-858
2017
-
A Brief History. Impact of the Advances in Ischaemic Heart Disease
Revista Espanola de Cardiologia Suplementos, Vol. 17, pp. 2-6
-
Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort
Medicine (United States), Vol. 96, Núm. 38
2016
-
ESPAMACS: el nuevo Registro Español de Asistencia Mecánica Circulatoria
Cirugia Cardiovascular, Vol. 23, pp. 7-14
-
Necesidades no cubiertas con el tratamiento hipolipemiante oral: documento de posición de la Sociedad Española de Cardiología
Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1083-1087